Novel risk models for early detection and screening of ovarian cancer.
Authors
Russell, MD'Amato, A
Graham, C
Crosbie, E
Gentry-Maharaj, A
Ryan, A
Kalsi, J
Fourkala, E
Dive, Caroline
Walker, M
Whetton, A
Menon, U
Jacobs, I
Graham, R
Affiliation
Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, ManchesterIssue Date
2017-01-03
Metadata
Show full item recordAbstract
Ovarian cancer (OC) is the most lethal gynaecological cancer. Early detection is required to improve patient survival. Risk estimation models were constructed for Type I (Model I) and Type II (Model II) OC from analysis of Protein Z, Fibronectin, C-reactive protein and CA125 levels in prospectively collected samples from the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).Citation
Novel risk models for early detection and screening of ovarian cancer. 2017, 8(1):785-797 OncotargetJournal
OncotargetDOI
10.18632/oncotarget.13648PubMed ID
27903971Type
ArticleLanguage
enISSN
1949-2553ae974a485f413a2113503eed53cd6c53
10.18632/oncotarget.13648
Scopus Count
Collections
Related articles
- Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
- Authors: Menon U, Gentry-Maharaj A, Burnell M, Ryan A, Kalsi JK, Singh N, Dawnay A, Fallowfield L, McGuire AJ, Campbell S, Skates SJ, Parmar M, Jacobs IJ, UKCTOCS team
- Issue date: 2025 May
- A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours.
- Authors: Russell MR, Graham C, D'Amato A, Gentry-Maharaj A, Ryan A, Kalsi JK, Ainley C, Whetton AD, Menon U, Jacobs I, Graham RLJ
- Issue date: 2017 Aug 22
- Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS.
- Authors: Bedia JS, Jacobs IJ, Ryan A, Gentry-Maharaj A, Burnell M, Singh N, Manchanda R, Kalsi JK, Dawnay A, Fallowfield L, McGuire AJ, Campbell S, Parmar MKB, Menon U, Skates SJ
- Issue date: 2025 Feb
- Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer.
- Authors: Yang WL, Gentry-Maharaj A, Simmons A, Ryan A, Fourkala EO, Lu Z, Baggerly KA, Zhao Y, Lu KH, Bowtell D, Jacobs I, Skates SJ, He WW, Menon U, Bast RC Jr, AOCS Study Group
- Issue date: 2017 Oct 1
- Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial.
- Authors: Pinsky PF, Zhu C, Skates SJ, Black A, Partridge E, Buys SS, Berg CD
- Issue date: 2013 May 1